3M Company

(New York Stock Exchange)
Back to all articles
Bullish +65

How the 3M Stock Turnaround Is Happening Faster Than Expected

AI-generated analysis

πŸ“ˆ 3M is executing a swift turnaround driven by stronger operational execution and margin expansion following years of litigation pressure.

πŸš€ On-time, in-full (OTIF) deliveries have improved significantly from the low 80% range to about 90%, with some consumer units reaching mid-90% rates.

πŸ’° The company plans over 350 product launches this year, with new products expected to comprise 20% of sales by the end of 2027.

πŸ”¬ Expanded beam optical technology is a key growth driver, expected to generate roughly $400 million in growth above underlying markets this year.

πŸ“Š Q2 adjusted net sales grew 5.5% year-over-year to $6.50 billion, with organic growth of 5.4% across safety & industrial and transportation segments.

πŸ’΅ Adjusted operating income increased by 7.2% year-over-year to $1.62 billion in the second quarter.

🎯 3M raised its fiscal 2026 EPS target from $8.50 to $8.95, reflecting a revised growth expectation of 9% to 11%.

πŸ“‰ The stock trades at a forward-adjusted P/E ratio of 18.18x, which is lower than the industry average of 19.17x.

πŸ‘ Wall Street consensus rating is 'Moderate Buy' with a price target of $187.81, implying a 15.5% upside from current levels.

⚠️ Some analysts like Bernstein maintain an 'Underperform' rating due to concerns about the nature of product innovations and lingering PFAS risks.

Bullish Signals
  • 3M is executing a faster-than-expected turnaround driven by stronger execution, margin expansion, and improved operational efficiency.
  • The company raised its fiscal 2026 organic sales growth target from approximately 3% to more than 3.5% following strong Q2 results.
  • Adjusted operating income increased by 7.2% year-over-year to $1.62 billion in the second quarter, demonstrating improved profitability.
  • New products are expected to account for 20% of sales by the end of 2027, driven by a planned portfolio of over 350 launches this year.
  • Expanded beam optical technology is projected to generate roughly $400 million in growth above underlying markets this year.
  • The stock trades at a forward-adjusted P/E ratio of 18.18x, which is cheaper than the industry average of 19.17x.
Risk Factors
  • Some analysts, including Bernstein, maintain an 'Underperform' rating citing concerns that product innovations lean toward incremental rather than transformative changes.
  • Analysts remain cautious about confirming structural improvement after just one strong quarter and view PFAS liabilities as a material ongoing risk.
Full Analysis
Industrial conglomerate 3M (MMM) is executing a faster-than-expected turnaround driven by improved operational efficiency and margin expansion. The company has successfully navigated significant litigation headwinds, including over $10 billion in settlements regarding PFAS pollution and a $6 billion payment for hearing loss claims related to veteran earplugs. CEO William Brown highlighted substantial improvements in on-time, in-full (OTIF) deliveries, which have risen from the low 80% range to approximately 90%, with some consumer units reaching mid-90% rates. Financial performance has strengthened alongside operational gains. In the second quarter, 3M reported adjusted net sales growth of 5.5% year-over-year to $6.50 billion, while adjusted operating income increased by 7.2% to $1.62 billion. The company is aggressively pursuing growth through innovation, planning more than 350 product launches this year with new products expected to account for 20% of sales by the end of 2027. Specifically, expanded beam optical technology is projected to generate roughly $400 million in growth above underlying markets this year. Based on these robust results, 3M has raised its financial targets for fiscal 2026, increasing its organic sales growth target from approximately 3% to more than 3.5%. The company also revised its EPS guidance upward, reflecting expectations of 9% to 11% growth compared to the prior outlook. Wall Street analysts have responded positively to these developments, with a consensus 'Moderate Buy' rating and a price target representing a 15.5% upside from current levels, though some firms remain cautious regarding long-term structural improvements.